Antineoplastic Protocols MeSH Descriptor Data 2025

MeSH Heading: Antineoplastic Protocols
Tree Number(s): E02.183.750; E02.319.077; N05.715.360.330.125.500
Unique ID: D024221
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D024221
Annotation: coord with COMBINED MODALITY THERAPY if pertinent
Scope Note: Clinical protocols used to inhibit the growth or spread of NEOPLASMS.
Entry Term(s): Cancer Treatment Protocols
Previous Indexing: Antineoplastic Combined Chemotherapy Protocols (1983-2001)
Public MeSH Note: 2002
History Note: 2002
Date Established: 2002/01/01
Date of Entry: 2001/07/25
Revision Date: 2018/06/30

Allowable Qualifiers: classification (CL)

standards (ST)

Therapeutics [E02]
- Clinical Protocols [E02.183]
  - Antineoplastic Protocols [E02.183.750]
    - Antineoplastic Combined Chemotherapy Protocols [E02.183.750.500]
  - Standing Orders [E02.183.875]

Therapeutics [E02]
- Drug Therapy [E02.319]

Health Care Quality, Access, and Evaluation [N05]
- Quality of Health Care [N05.715]
  - Health Care Evaluation Mechanisms [N05.715.360]
    - Epidemiologic Study Characteristics [N05.715.360.330]
      - Clinical Protocols [N05.715.360.330.125]
        
        Antineoplastic Protocols [N05.715.360.330.125.500]
        
        Clinical Trial Protocols as Topic [N05.715.360.330.125.625]
        
        Standing Orders [N05.715.360.330.125.750]

Antineoplastic Protocols Preferred

page delivered in 0.147s